12:00 AM
 | 
Sep 21, 2009
 |  BC Week In Review  |  Company News  |  Deals

Huya, Guangzhou Institutes of Biomedicine and Health deal

Huya received an option to exclusively license certain compounds owned or controlled by the government-sponsored...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >